Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CiproPAL trial of ciprofloxacin prophylaxis during induction for paediatric acute lymphoblastic leukaemia
ISRCTN21195635Phase 3Recruiting
- Sponsor
- University College London
- Start
- Jun 2022
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial in acute lymphoblastic leukemia (ALL) comparing Ciprofloxacin prophylaxis with Standard of care antibiotic policy (2 arms). Primary endpoint: Rate of sterile site bacterial infections during induction. Started Jun 2022; status: recruiting.
02
Drugs
ciprofloxacin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on ISRCTN21195635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN21195635.